Abstract. Alzheimer's disease (AD) may affect all cell types in the central nervous system. Astrocytes have rarely been investigated in the aged brain and the role of astrocytes in AD is poorly understood. In this study, we used acute brain slices from an amyloid-β overexpressing double transgenic mouse line where astrocytes express the enhanced green fluorescent protein under the control of the glial fibrillary acidic protein promoter. Using the patch-clamp technique, we analyzed cell coupling and glutamate reactivity, two main features of astrocytes, in the living tissue of aged mice in an AD mouse model. We found large astrocytic networks in the aged (20 to 27 months) transgenic animals in the neocortex, but not in the hippocampus. In contrast, coupling was low in all brain regions of aged control mice. We furthermore noticed significant changes in the responses of astrocytes to glutamate. The expression of functional glutamate transporters and AMPA/kainate-type glutamate receptors increases in the amyloid-β protein precursor overexpressing mice. Thus, exposure to amyloid-β leads to altered astrocyte properties and this change might be beneficial to maintain synaptic function.
INTRODUCTION
In the first histopathological description of Alzheimer's disease (AD), Alois Alzheimer recognized amyloid-β (Aβ) deposits, which were associated not only with degenerating neurons but also with activated glial cells [1] . These were later recognized as microglia and astrocytes. Microglial cells are the classical pathologic sensors of the brain [2] . Today it is well established that microglial cells influence the pathologic process in AD, e.g., by governing an inflammatory response or by phagocytosis of Aβ. Additionally, astrocytes undergo changes in response to pathology by releasing a variety of cytokines and chemokines [3] , by changing their morphology, and by an increase in the expression of the typical astrocyte marker protein, glial fibrillary acidic protein (GFAP) [4] . Histopathological studies within the last few years revealed that Aβ peptides of different lengths accumulate in astrocytes, implying that these cells play a role in plaque development [5] [6] [7] . More recently, astrocytes have also been shown to have the capability to degrade Aβ [8, 9] .
A number of functions have been assigned to astrocytes in the normal brain. Specifically, they have been considered as modulators of neuronal activity and synaptic transmission [10, 11] (and reviewed in [12] ). Astrocytes are important elements for controlling extracellular neurotransmitter levels, especially of the major excitatory transmitter glutamate. Astrocyte glutamate uptake and metabolism is of crucial importance for glutamatergic neurotransmission, and a disturbance of this uptake system severely affects neuronal communication [13, 14] . Glutamate in high concentrations is toxic for neurons. This excitotoxicity is mediated by an excessive stimulation of NMDA-receptors, Ca 2+ -permeable subtypes of glutamate receptors. Chronic NMDA-receptor activation can lead to an intracellular Ca 2+ overload and subsequent neuronal death [14] . Excitotoxicity may also contribute to neuronal loss in AD, since the non-competitive NMDA-receptor antagonist memantine has been shown to enhance cognitive function and to limit neurodegeneration [15] .
Another important role for astrocytes is the control of extracellular K + homeostasis. This function is facilitated and fostered by large astrocyte networks, coupled via gap-junctions as described for acute slices from the young mouse brain [16] . In older animals, the expression of gap junction proteins appears to be lower [17] , but not much is known to date about the functional coupling of astrocytes in aged mice or in AD-pathology. Apart from a few experiments [18] , electrophysiological properties in conjunction with coupling have not yet been investigated in detail in aged mice.
In the present study, we investigated the physiological properties of aged vital astrocytes in a mouse model of AD in situ. Astrocytes within the neocortex and the hippocampus were characterized with respect to cell coupling and their pattern of functional AMPA/kainate glutamate receptor and/or glutamate transporter expression.
MATERIALS AND METHODS

Animal model and slice preparation
Transgenic mice, in which a human amyloid-β protein precursor (AβPP) minigene encoding the APP 717V →F mutation is driven by a platelet-derived growth factor (PDGF)-β promoter (PDAPP [19] ), were crossbred with transgenic mice characterized by an enhanced green fluorescent protein (EGFP) driven by the glial fibrillary acid protein promoter (GFAP-EGFP [4] ) to generate PDAPP +/− /GFAP-EGFP +/− double or PDAPP −/− /GFAP-EGFP +/− single transgenic mice ( Supplementary Fig. 1 ). All experiments were performed in accordance with the German ethical guidelines for handling of animals. The transgenic mice (PDAPP +/− /GFAP-EGFP +/− ) used for the experiments were 21-28 months old. Mice not carrying the PDAPP mutation (PDAPP −/− /GFAP-EGFP +/− ) served as controls (17-27 months old). In some experiments, EGFP-transgenic mice (GFAP-EGFP +/− or GFAP-EGFP +/+ ) were used as controls (P7-P10 or 12-14 months). Animals were decapitated, and their brains were removed and mounted in a chamber with ice-cold bicarbonate-buffered artificial cerebrospinal fluid (aCSF), composed of (in mM): 134 NaCl, 2.5 KCl, 1.3 MgCl 2 , 2 CaCl 2 , 1.25 K 2 HPO 4 , 10 Glucose, 26 NaHCO 3 , continuously gassed with 95% O 2 and 5% CO 2 . Brain tissue was cut into 150 µm thick coronal slices using a vibratome (VT 1000S, Leica, Heidelberg, Germany) equipped with a sapphire blade. Slices were stored in aCSF for at least 1 hour before the experiments were conducted.
Patch clamp, pharmacology, and recordings
Slices were gently transferred into a submerged chamber and constantly perfused with aCSF at room temperature. Astrocytes were identified by their green fluorescence using a Zeiss Axioskop (Jena, Germany), appropriate filters, and a monochromator (Polychrome IV, Till Photonics, Martinsried, Germany) with a CCD camera (Sensicam, PCO, Kelheim, Germany), using custom-made software.
Cells located deeper than approximately 10 µm under the slice surface were patched in whole-cell configuration as described in Schipke and colleagues [20] . Current signals were amplified (EPC-9 or EPC-10 amplifier, HEKA, Lambrecht, Germany), filtered at 3 kHz and sampled at 5 kHz by an interface (HEKA) connected to a PC system, which also served as a stimulus generator. All patch clamp data analysis was performed using the Tida software package (HEKA). Patch pipettes were pulled from Borosilicate capillaries (Hilgenberg, Malsfeld, Germany) using a P-2000 laser based puller (Sutter Instruments, Novato, CA). The patch pipettes had a resistance of 3-6 MΩ and were filled with a solu-tion containing (in mM): 130 KCl, 2 MgCl 2 , 0.5 CaCl 2 , 5 EGTA, 10 HEPES, 2 Na 2 -ATP, and 0.5% biocytin (Nε-Biotinyl-l-Lysine, Sigma, St. Louis, MO). The pH was adjusted to 7.3.
Current responses in patched cells were evoked by de-and hyperpolarizing the membrane between −170 and 10 mV in 10 mV steps for 50 ms. Testing for the functional expression of glutamate transporters was performed by perfusing the slice with aCSF containing 0.5 mM D-aspartate (Sigma, Germany) for 30 s. After at least 120 s of washing with pure aCSF, the slice was perfused with aCSF containing 0.5 mM kainate for 30 s to test for functional expression of AMPA-type glutamate receptors. During the entire experiment, the membrane of the patched cell was repetitively clamped to a series of de-and hyperpolarizing potentials from 50 mV to −170 mV (20 mV increments) from a holding potential of −70 mV to study the conductance changes after application of D-aspartate and kainate (both from Tocris, Ellisville, Missouri). We found consistently that the input resistance of astrocytes increased with recording time. For the glutamate pharmacology, only cells with a stable membrane potential and an input resistance not higher than 50 MΩ during the application of kainate and D-aspartate were included in the data analysis.
Tissue processing and intracellular labeling
Slices were fixed in 4% paraformaldehyde and 0.1% glutaraldehyde in 0.1 M sodium phosphate buffer (PB) at a pH of 7.4 overnight at 4
• C. Only one cell per hemisphere was filled with biocytin. Biocytin detection was performed using the free floating method as described in D'Ambrosio et al. [21] with some minor modifications: After fixation, slices were washed in 0.1 M PB (3 × 20 min) and in 0.1 M Tris-HCl buffer (TB) at pH 7.4 (2 × 20 min). Endogenous peroxidases were suppressed with 1% H 2 O 2 in 0.1 M TB at pH 7.4 (2 hours). The slices were pretreated with 2% bovine serum albumin (BSA) (Sigma-Aldrich, Munich, Germany), 0.25% dimethylsulfoxide (DM-SO, Sigma-Aldrich), and 0.05 M Tris-buffered saline (TBS) at pH 7.4 (1 hr) to reduce nonspecific background staining and to permeabilize membranes. Slices were washed in 0.1 M TBS at pH 7.4 (30 min) and then incubated using the Vectastain Elite ABC kit Standard (Axxora, Grünberg, Germany), which was diluted 1:500 in 0.5% BSA, 0.25% DMSO, and 0.05 M TBS (36-48 hoours) at 4
• C. Slices were washed thoroughly in 0.1 M TBS (3 × 20 min) followed by 0.1 M TB at pH 7.6 (3 × 20 min), preincubated in 0.025% 3,3'-diaminobenzidine (DAB) with 0.005% NiCl 2 (SigmaAldrich) to increase the density of stain for 15 min, and then incubated with fresh DAB and NiCl 2 solution containing 0.002% H 2 O 2 for 60 min. The reaction was halted by washing in 0.1 M TB (2 × 20 min). Counterstaining for extracellular Aβ plaques was performed with Congo red (Fa. Carl Roth, Karlsruhe, Germany): (1) Slices were washed in water (2 × 10 min) and then (2) incubated with 1% Congo red in water (1 min), (3) differentiated with saturated Lithiumcarbonate (SigmaAldrich) in water for 15 s and (4) washed 80% Ethanol (2 × 20 min).
Step 3 and 4 were repeated 2-3 times. Finally slices were washed in water (20 min), mounted with Aqua Polymount (Polyscience Inc., Eppelheim, Germany) on gelatine-subbed slides, and stored at 4
• C to preserve the fluorescence.
Statistical analysis
For each distribution, a Chi Square test was performed to test whether the observed frequencies differ significantly from the expected frequencies.
* p < 0.05, * * p < 0.005
RESULTS
Astrocytes in hAβPP overexpressing mice display signs of activation
To determine the impact of AβPP and the formation of amyloid plaques on the properties of astrocytes in situ, we crossbred two transgenic mouse lines, the PDAPP +/+ or PDAPP +/− [19] and GFAP-EGFP +/+ or GFAP-EGFP +/− transgenic mice [4] to obtain double transgenic animals (AβPP double-Tg, brain tissue (Fig. 1a-f ) or brain slices, which were used for electrophysiological studies before, were investigated (Table 1) . AβPP double-Tg mice developed first Aβ deposits at the age of nine months and showed a remarkable plaque load after one year, which is comparable with the occurrence and prevalence of plaques in single transgenic PDAPP +/+ mice [19] . In AβPP double-Tg mice, we had the impression that the density of EGFP-positive cells in the neocortex and the hippocampus was higher as compared to EGFP-positive cells in control double-Tg and control single-Tg mice. Astrocytes in the AβPP double-Tg mice had a larger soma and thicker processes. This was, however, difficult to quantify since the number of EGFP+ astrocytes was low and images in acutely isolated slices as used in the electrophysiological experiments did not have sufficient resolution to evaluate cell morphology. In slices from perfusion-fixed brains, brightly green fluorescent astrocytes were frequently found in the proximity of Aβ deposits and we occasionally observed astrocyte processes directly associated with the Aβ deposits (Fig. 1) . In brain areas devoid of Congo red-stained Aβ plaques, we observed weaker fluorescent cells with small condensed somata and very thin processes (Fig. 1b, white arrow) , comparable to those observed in aged control animals. The enhanced EGFP expression in AβPP double-Tg mice can most likely be attributed to an increased activi- Table 1 Cells analyzed for network properties in the neocortex and in the hippocampus. The first rows indicate the number of coupled cells after injection of a single cell ty of the GFAP promoter and a manifest astrogliosis caused by the amyloid pathology. These morphological differences of EGFP-positive astrocytes in our animal model of AD were apparent only in thin slices (50 µm) obtained from perfusion-fixed brain tissue but not in the thicker slices used for electrophysiological experiments. As a consequence, we could not select a certain subgroup of astrocytes for electrophysiological characterization and the number of cells observed in slices from perfusion-fixed brains was too low to obtain statistical significant values.
Dye coupling of aged astrocytes in control mice is low but enhanced in the neocortex of AβPP double-Tg animals
Green fluorescent cells in the neocortex and in the hippocampus of aged mice were randomly selected and the membrane currents were studied with the patch clamp technique. To determine the extent of cell coupling among astrocytes, we dialyzed cells for 20 min with biocytin via passive diffusion from the patch pipette. After fixation of the slice, biocytin labeling was visualized using the ABC-DAB method, and the number of labeled cells as well as the area covered by the network were analyzed. In addition, in AβPP double-Tg mice, the distance from the edge of the network to the next amyloid plaque stained with Congo red was determined.
Astrocytes form large syncytia in brains of young mice [22] . Using the standard technique described above, we were not able to stain astrocyte networks in the neocortex (NC) of control double-Tg animals (n = 6 cells injected). In the hippocampus (HC) of control double-Tg mice, only three networks were detected among of 20 injected cells (Table 1) . To confirm the finding that cell coupling of astrocytes in aged mice differs from coupling in young animals, we analyzed the network forming properties of astrocytes in aged control single-Tg animals. Mice older than 12 months of age were defined as aged mice. In brain slices from these mice, we also did not observe astrocyte networks (n = 40 injected cells, n = 19 in NC, n = 21 in HC) as they are known from young mice (Fig. 2a, top) . Instead, astrocytes with one or two neighboring cells were occasionally detected (n = 1 in NC, n = 4 in HC, Fig. 2a, bottom) . In a few cases, weakly stained astrocyte networks were found that could not be followed up and analyzed due to their pale staining and no visual appearance of astrocyte somata (n = 1 in NC, n = 2 in HC, data not shown). When we applied the same protocol to young mice, we found large networks as previously described [23] . Together these findings indicate that functional astrocyte coupling, measured by passive diffusion of biocytin in old mice, is much lower as compared to young mice.
In contrast, in aged AβPP double-Tg mice, we observed biocytin-labeled networks of cells in 11 out of 21 experiments in the neocortex (representative examples are given in Fig. 2b, top and bottom) . The amount of biocytin-labeled cells ranged from 10 to about 100. Analyses of the area, the circumference, and the density of each astrocyte network are provided in Table 1 . In the hippocampus of AβPP double-Tg mice, we detected only one astrocyte syncytium out of 13 cells investigated (Table 1) .
Membrane currents distinguish two types of astrocytes in the aged brain
The membrane currents were recorded by applying repetitive voltage jumps from the holding potential of −80 mV in 10 mV increments to −170 mV and +10 mV respectively (Fig. 3) . We observed two types of membrane currents in the aged brain: 1) passive currents with a linear current to voltage relationship (passive cells, Fig. 3a) and 2) delayed activating outward currents superimposed to passive currents with an outward-rectifying current to voltage relationship (outward-rectifying cells, Fig. 3b ).
In the neocortex of aged control double-Tg mice, outward-rectifying astrocytes constituted a small population (20%, n = 20), while the majority was passive. In the neocortex of AβPP double-Tg mice (n = 60 in NC), the percentage of outward-rectifying cells was in a similar range, namely 12% (Fig. 3c) . In contrast, in the hippocampus of control double-Tg animals (n = 52 in HC), about half of the astro- cytes were outward-rectifying, the other half passive (52% outward-rectifying, 48% passive, Fig. 3d ). In AβPP double-Tg mice (n = 60), the relation between outward-rectifying and passive cells was in a similar range (63% outward-rectifying, Fig. 3d ). Even in slices, where amyloid plaques were identified within 100 µm of the patched cell as determined by Congo red-staining after the experiment, the percentage of outward-rectifying cells was in a similar range (66%, n = 9, Fig. 3e and supplemental material Table 1S ). This data indicates that there are two populations of astrocytes with respect to membrane currents in aged animals and that this distribution did not significantly change in this AD mouse model (supplemental Table 1S ).
The population of astrocytes sensitive to kainate and D-aspartate increases in the AD mouse model
To characterize the functional expression of glutamate transporters and AMPA/kainate-type glutamate receptors in astrocytes, D-aspartate, and kainate, respectively, were subsequently applied during the patch clamp experiment while monitoring the membrane current (Fig. 4a) . When cells were clamped at −70 mV, both kainate and D-aspartate elicited inward currents in some, but not all cells. 90% of the cells responding to kainate, both in AβPP double-Tg as well as in the control double-Tg animals, expressed outward-rectifying membrane currents. Cells with passive currents were more heterogeneous in that they were responsive to Daspartate only, to both kainate and D-aspartate, or to none at all (data not shown).
In control double-Tg mice, a small population of cells (NC: 15%, HC: 6%) responded to both kainate and D-aspartate (Table 2 , investigated cells n = 13 in NC, n = 33 in HC; Fig. 4b and c, black areas) . This population was significantly higher in AβPP doubleTg mice, namely 47% in the neocortex and 18% in the hippocampus (investigated cells n = 30 in NC, n = 33 in HC). In the hippocampus, cells closely located to an amyloid plaque (< 100 µm) always showed some response either to kainate or both, kainate and D-aspartate (Fig. 4d) .
Conversely, in control double-Tg mice a substantial number of astrocytes (NC: 31%, HC: 37%) neither responded to D-aspartate nor to kainate (Fig. 4b and c,  white areas) . In AβPP double-Tg mice (investigated cells n = 30 in NC, n = 33 in HC), the number of non-responsive astrocytes was much lower in both the neocortex and the hippocampus and this difference is statistically significant ( Table 2 , NC: 23%, HC: 6%; Fig. 4b and c, white areas) .
The overall population of astrocytes responding to kainate, including cells responding additionally to D- Table 2 Cells analyzed for pharmacological properties in the neocortex (NC) and in the hippocampus (HC) aspartate, was increased in AβPP double-Tg mice in both brain regions (NC: 38% vs. 67%, HC: 63% vs. 88%, Fig. 5a ). Astrocytes that were responsive to both kainate and D-aspartate accounted for this increase (Fig. 5a , solid black part of bars), while cells responding only to kainate almost remained stable (Fig. 5a , black dotted part of bars). The amplitude of all kainateinduced responses was in between 58 pA and 1780 pA, of D-aspartate-induced responses in between 26 pA and 370 pA. In contrast to earlier studies performed in young control double-Tg animals, in the hippocampus of aged control double-Tg mice we did not find cells that were only responsive to D-aspartate, but not kainate. In the hippocampus, only few cells responded to both agonists in control double-Tg mice (HC: 6%, Fig. 5b ). In AβPP double-Tg mice, the amount of cells showing responses to D-aspartate and to both agonists was significantly higher (HC: 18%, Fig. 5b ). We could not associate cells with a defined response pattern to different brain regions.
Also in the neocortex, the total number of astrocytes exhibiting D-asparte-induced responses was higher in the AβPP double-Tg mice (NC: 46% vs. 57%, Fig. 5b ). This was again mainly due to an increase in the population of cells responding to both, kainate and aspartate. The number of astrocytes responding to D-aspartate only even decreased in the neocortex (31% to 10%, Fig. 5b , white dotted part of bars).
DISCUSSION
Astrocytes are increasingly being recognized as crucial entities of the central nervous system, as they play an important role not only in physiological conditions, where they are involved in the synaptic transmission and plasticity reviewed in [12] , but also in the context of several brain pathologies such as strokes [24] and epilepsy [25, 26] .
AD affects all brain cell types, neurons, and glia cells. The first steps in the pathophysiology of AD are not fully understood; dysregulation of AβPP processing and metabolism may not be the earliest event in the disease stages, but Aβ plaque formation is an important hallmark leading to inflammation and massive loss of functional brain tissue [3] . Astrocytes internalize Aβ [5, 6, 27] and have the capacity to degrade amyloid [8, 9] . The changes in astrocyte physiology caused by chronic AD-like pathology have not been investigated. To overcome one of the major obstacles, the identification of living astrocytes in situ, we crossbred two different transgenic mouse strains, PDAPP-overexpressing [19] and GFAP-EGFP transgenic mice [4] , and allowed the offspring to age for more than 20 months. The expression of green fluorescent astrocytes in the double transgenic mice allowed us to investigate the properties of astrocytes in living brain preparations from aged mice showing an AD-like pathology, including the formation of Aβ containing plaques. As soluble Aβ cannot be visualized in our model, we could not determine the impact of soluble Aβ onto astrocytes. In addition to astrocytes, hippocampal NG2 cells can also express EGFP in the juvenile GFAP-EGFP mouse model, but the expression level was much lower which allowed us to distinguish these two cell types based on their EGFP fluorescence.
The majority of astrocytes are in contact with amyloid pathology
Amyloid plaques were not visible in living brain slices using brightfield optics. To control the influence of plaques in close proximity to the investigated astrocytes, we attempted to visualize Aβ deposits in situ. After adding Congo red to the aCSF, we failed to detect vital astrocytes for patch clamp analysis, most likely due to the toxic effects of the dye.
Astrocytes therefore had to be randomly selected and the distance to the next Aβ plaque was determined by staining with Congo red after fixation of the slice at the end of the in situ experiment. This technique has several limitations: The limited diffusion of Congo red into the tissue (slice thickness 150 µm) and the fact that generally cells within approximately 20 µm beneath the surface of the slice were investigated, do not exclude the presence of plaques in the proximity of astrocytes or astrocyte networks even when no Congo red staining was detected. For the hippocampus, we calculated the percentage of cells which are with distance of < 100 µm to a plaque (Table 1) . Assuming a spherical geometry with the radius of 100 µm around each astrocyte, with the given plaque load, more than 80% of the astrocytes in AβPP double-Tg animals are < 100 µm to amyloid plaque. Moreover, Congo red preferentially stains aggregated fibrils with a β-sheet conformation [28] , thus most likely not all amyloid fragments can be stained and the overall amyloid burden in the brain is underestimated. We therefore refrain from highlighting the absence of plaques when no Congo red staining was detected.
Characteristics of astrocyte morphology and networks in the aged brain
The extent of functional coupling in astrocyte networks of older animals is not well characterized. The expression of astrocytic gap junction proteins decays to a certain degree, but evidence for coupling was still reported in the hippocampus of aged mice [17] . Coupling in the cortex and electrophysiological properties in general have not been investigated in aged mice. It is well known that astrocytes in young mice form large syncytia in the neocortex [23] and in the hippocampus [18] . This astrocytic syncytium has been attributed to play an important role in K + -homeostasis [16] and in the propagation of intercellular calcium waves [23, 29, 30] .
In our study we compared the spread of biocytin in young, aged, and AβPP double-Tg aged animals. We could confirm that, in young animals (P 12), biocytin spreads to a large network after injection into a single astrocyte. In contrast, using the same approach, we rarely observed biocytin spread in the aged mice. Astrocytes in the brains of aged mice cells were not coupled regardless of the genotype. Furthermore we found a fundamental difference of astrocyte morphology in the aged brain. Using the standard technique of biocytin staining [21] , astrocyte processes could not be visualized and the somata of biocytin-filled cells appeared remarkably smaller compared to astrocytes in young mice (Fig. 3b) . This tendency has been observed before in up to 4 months old rats [31] . Thus, the restricted diffusion as a cause of more closely apposed membranes and consequently less cytosol as diffusion space in the astrocyte processes might contribute to the low astrocytic dye-coupling in the aged, healthy brain.
Altered astrocytic morphology and coupling
In aged AβPP double-Tg mice, we were able to detect astrocyte syncytia reminiscent of glial networks in young mice [22] . The somata of single astrocytes still appeared smaller and cell processes were rather fine compared to young mice. In comparison to controls, the soma was larger and the processes distinctly visible in AβPP double-Tg mice were similar to activated astrocytes found in the proximity of a stab-wound [4] or a focal ischemic lesion (our own unpublished observation). It has been described before in cell culture that extracellular glutamate enhances astrocytic coupling [32] and that enhanced extracellur glutamate levels are pathognomic in AD [14] . Previous evidence has shown that the expression of the gap-junction protein connexin43 (Cx43) is enhanced in astrocytic gap junctions within the AD brain. Plaques were often observed neighboring with the sites of enhanced Cx43 immunoreactivity [33] . Astrocytes might respond to these high levels of glutamate with an enhanced coupling efficiency. Also, blocking astrocytic gap junctions during a glutamate insult leads to an increased neuronal injury [33] . The alteration of astrocytic gap junctional coupling in AD might therefore play a neuroprotective role, preserving neurons from a glutamate-induced cell death. This effect is obviously only present in the neocortex, while in the hippocampus, different properties of astrocytes may limit the re-formation of large astrocyte networks, or the alterations observed in the neocortex may appear at later disease stages.
Glutamatergic functions of astrocytes
An important function of astrocytes at the tripartite synapse is to remove glutamate from the extracellular space in both physiological and pathophysiological conditions. To fulfill this function, astrocytes may express high densities of glutamate transporters (reviewed in [35] ) as well as ionotropic glutamate receptors, both NMDA- [20] and AMPA/kainatetype receptors [36] . Interestingly, a change in the expression of these receptors has also been detected in the context of ischemia [37] . In the hippocampus of young mice, highly fluorescent GFAP/EGFP-positive astrocytes express glutamate transporters, but not the AMPA/kainate-type receptor, while another population of glial cells expresses glutamate receptors of the AMPA/kainate-type [38] . Since we used kainate as a potent agonist, we did not distinguish between kainateand AMPA receptor-mediated responses. Based on the studies from juvenile animals which express AMPA receptors, we assume that this pattern is similar in the aged brain. We were also careful not to over interpret our quantitative measures of neurotransmitter-induced currents since we are aware that the complex morphology of these cells results in significant space-clamp problems. In the aged brain, we found an astrocyte population that exhibits AMPA/kainate-type receptors and glutamate transporter function in the neocortex and the hippocampus. This multipotent astrocyte population was significantly increased in AβPP double-Tg mice and we provide the first report on levels of glutamate transporters in this mouse model. We conclude from the data of this study that astrocytes adapt to the changing environment where the ambient glutamate concentration changes and the need for efficient glutamate transport to maintain the synaptic function are much higher.
AMPA/kainate-type glutamate receptors as astrocytic sensors for excessive levels of extracellular glutamate
The function of AMPA/kainate-type receptors in astrocytes is still speculative, but it has become evident that its expression is essential for synaptic integrity. Interference with AMPA receptor expression in Bergmann glial cells, an astrocyte type in the cerebellum, leads to significant synaptic derangements in the molecular layer [39] . Our finding in our AD mouse model that the population of astrocytes showing glutamate receptor-mediated responses increases significantly in the hippocampus, where the highest glutamate burden may take place, led to the speculation that functional AMPA/kainate-type glutamate receptors on astrocytes serve as a sensor to detect excessive amounts of glutamate. More cells also show glutamate transporter function that will help to protect the neurons from excitotoxic damage.
The functionality of receptors and transporters for glutamate might also be linked to yet another function of astrocytes: the release of glutamate. In the same AβPP-overexpressing mouse strain used in our study, it has been shown that astrocyte glutamate release is impaired [40] . The altered glutamatergic function of astrocytes as described in this study could be a response to compensate for the aberrant network excitability [41] and impaired synaptic plasticity [42] [43] [44] .
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